Network Toscana Life Sciences: Single Item

1. A Process Of Controlled Radical Grafting Of A Polyolefin - [05/04/2006]

2. Haptic Interface Device - [01/03/2006]

3. Haptic Interface Device - [01/03/2006]

4. Bioreactor For Studying The Effects Of Imposed Stimuli On Cellular Activity - [29/12/2005]

5. Method And System For Scheduling Synchronous And Asynchronous Data Packets Over The Same Network - [03/11/2005]

6. Hybrid Drive Assembly For A Vehicle, In Particular A Scooter - [14/09/2005]

7. A Process Of Controlled Radical Grafting Of A Polyolefin - [14/04/2005]

8. A Wearable Mechatronic Device For The Analysis Of Joint Biomechanics - [03/03/2005]

9. Ultrasound-assisted Ischemic Reperfusion - [17/02/2005]

10. A Process Of Controlled Radical Grafting Of A Polyolefin - [29/12/2004]

11. A Process Of Controlled Radical Grafting Of A Polyolefin - [29/12/2004]

12. Electroactive Polymer Contractible Actuator - [16/12/2004]

13. Electroactive Polymer Contractible Actuator - [16/12/2004]

14. Integrated Antenna Commutator For Mobile Terminals - [16/12/2004]

15. Novel Citrullinated Synthetic Peptides And Uses Thereof - [14/10/2004]

16. Citrullinated Synthetic Peptides And Uses Thereof - [14/10/2004]

17. Hybrid Drive Assembly For A Vehicle, In Particular A Scooter - [09/07/2004]

18. Hybrid Drive Assembly For A Vehicle, In Particular A Scooter - [09/07/2004]

19. Hybrid Drive Assembly For A Vehicle, In Particular A Scooter - [01/07/2004]

20. Method Of Producing Cultured Pearls - [30/06/2004]

21. Method Of Producing Cultured Pearls - [24/06/2004]

22. Slitta Porta Campioni Ed Accessori Relativi Per L'analisi Di Sezioni Sottili Di Roccia. - [17/07/2003]

23. Slitta Porta Campioni Ed Accessori Relativi Per L'analisi Di Sezioni Sottili Di Roccia. - [17/07/2003]

24. Cleaning Composition - [28/05/2003]

25. Ophthalmic Composition Containing N-acetyl-cysteine For The Treatment Of Dry-eye Syndrome - [13/02/2003]

26. Ophthalmic Composition Containing N-acetylcysteine For The Treat Ment Of Dry-eye Syndrome - [13/02/2003]

27. Auxiliary Forceps For Hand-assisted Laparoscopic Surgery (hals) - [19/12/2002]

28. Proportional Valve With Shape Memory Alloy (sma) Actuator - [14/11/2002]

29. Radical Scavenger - [17/07/2002]

30. Cleaning Composition - [17/07/2002]

31. Estimation Of The Downlink Channel For Umts - [31/01/2002]

32. Slitta Porta Campioni Ed Accessori Relativi Per L'analisi Di Sezioni Sottili Di Roccia. - [17/01/2002]

33. Slitta Porta Campioni Ed Accessori Relativi Per L'analisi Di Sezioni Sottili Di Roccia. - [17/01/2002]

34. Use Of Niaouli Essential Oil As Transdermal Permeation Enhancer - [14/09/2000]

35. Device Operable To Supply A Force Feedback To A Physiological Unit To Be Used In Particular As An Advanced Interface For Machines And Computers - [15/06/1999]

36. Vorrichtung Um Ein Kraftabhaengiges Rueckfuehrsignal An Eine Physiologische Einheit Durchzugeben, Insbesondere Fuer Ein Interface Von Maschinen Und Computern - [02/06/1999]

37. Endoscopic Robot - [25/05/1999]

38. Surgical Drill With Bit Penetration Control And Breakthrough Detection - [07/05/1998]

39. Bioadhesive Complexes Of Polycarbophil And Azole Antifungal Or Antiprotozoal Drugs - [12/02/1998]

40. Device For Monitoring The Configuration Of A Distal Physiological Unit For Use, In Particular, As An Advanced Interface For Machine And Computers - [10/02/1998]

41. Vaccino Per La Profilassiimmunitaria Dell'infezione Da Virus Della Immunodeficienza Felina Del Gatto Domestico. - [31/10/1997]

42. Ophthalmic Solutions Viscosified With Tamarind Seed Polysaccharide - [14/08/1997]

43. Einrichtung Zur Ueberwachung Einer Distalen Physiologischen Einheit Zur Verwendung Als Hochentwickelte Schnittstelle Fuer Maschinen Und Rechner - [10/07/1997]

44. Vaccine For The Immunoprophylaxis Of The Infection From Feli Ne Immunodeficiency Virus In The Domestic Cat - [16/10/1996]

45. Vaccine For The Immunoprophylaxis Of The Infection From Feline Immunodeficiency Virus In The Domestic Cat - [03/10/1996]

46. Vaccino Per La Profilassiimmunitaria Dell'infezione Da Virus Della Immunodeficienza Felina Del Gatto Domestico. - [30/09/1996]

47. Vaccino Per La Profilassiimmunitaria Dell'infezione Da Virus Della Immunodeficienza Felina Del Gatto Domestico. - [30/09/1996]

48. Kollimator - [04/12/1969]

49. (missing Title) - [03/11/1969]

50. Universal-ganzkoerper-scanner - [06/02/1969]

1. Extensive solitary fibrous tumor of the retropharyngeal space. - [1/3/2006]

2. Perioperative dexamethasone reduces post-surgical sequelae of wisdom tooth removal. A split-mouth randomized double-masked clinical trial. - [1/3/2006]

3. Dopamine in neurotoxicity and neuroprotection: what do D(2) receptors have to do with it? - [1/3/2006]

4. Placental transfer of antibiotics administered to the mother: a review. - [1/2/2006]

5. Protective effect of l-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. - [1/2/2006]

6. Antimyoclonic effect of levetiracetam in MERRF syndrome. - [12/1/2006]

7. Dopamine agonists in the treatment of Parkinson's disease. - [1/1/2006]

8. Spontaneous blinking behaviour in persistent vegetative and minimally conscious states: relationships with evolution and outcome. - [30/12/2005]

9. Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers. - [27/12/2005]

10. Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction. - [1/12/2005]

11. Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. - [1/11/2005]

12. Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features. - [1/11/2005]

13. Ultrasonography of the temporomandibular joint: comparison of findings in patients with rheumatic diseases and temporomandibular disorders. A preliminary report. - [1/10/2005]

14. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis. - [1/10/2005]

15. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. - [1/10/2005]

16. Prevalence of right-to-left shunt in patients with cluster headache. - [1/9/2005]

17. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. - [1/9/2005]

18. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment. - [1/9/2005]

19. Pharmacokinetics of antivirals in neonate. - [1/9/2005]

20. From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. - [1/8/2005]

21. Anxiety symptoms in clinically diagnosed bruxers. - [1/8/2005]

22. Transfer of antivirals across the human placenta. - [1/8/2005]

23. Orbital decompression in graves' ophthalmopathy by medial and lateral wall removal. - [1/8/2005]

24. Impaired clearance of microemboli and cerebrovascular symptoms during carotid stenting procedures. - [1/8/2005]

25. Sulfation of drugs and hormones in mid-gestation human fetus. - [1/7/2005]

26. Mood disorders in subjects with bruxing behavior. - [1/7/2005]

27. Magnetic resonance of the temporomandibular joint: experience at an Italian university center. - [1/7/2005]

28. Coronoid hyperplasia. A case report. - [1/7/2005]

29. Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome. - [1/6/2005]

30. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. - [1/6/2005]

31. Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. - [20/5/2005]

32. Rizatriptan does not change cerebral blood flow velocity during migraine attacks. - [30/4/2005]

33. Postprocedural Emboli in Carotid Artery Stenting: Where Do They Come From? - [7/4/2005]

34. Cx26 gene mutations in idiopathic progressive hearing loss. - [1/4/2005]

35. Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study. - [1/4/2005]

36. Comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint disc displacement. - [1/4/2005]

37. Maxillary sinus augmentation with platelet-rich plasma and fibrinogen cryoprecipitate: a tomographic pilot study. - [1/3/2005]

38. Effects of prolonged wakefulness combined with alcohol and hands-free cell phone divided attention tasks on simulated driving. - [1/3/2005]

39. Sexual hormone serum levels and temporomandibular disorders. A preliminary study. - [1/2/2005]

40. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer. - [1/2/2005]

41. The IGF-1--IGFBPs system in the crevicular fluid: its changes during orthodontic movement. - [1/1/2005]

42. In vitro effects of different concentration of PRP on primary bone and gingival cell lines. Preliminary results. - [1/1/2005]

43. Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity. - [1/1/2005]

44. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial. - [1/1/2005]

45. Redistribution of cerebropetal blood flow in patients with carotid artery stenosis measured non-invasively with fast cine phase contrast MR angiography. - [1/1/2005]

46. Inclusion body myopathy associated with motor neuron syndrome: three case reports. - [1/1/2005]

47. Penetrating brain injuries from a dog bite in an infant. - [1/1/2005]

48. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? - [23/11/2004]

49. 17-beta-estradiol and progesterone serum levels in temporomandibular disorder patients. - [1/11/2004]

50. Comparison of masticatory dysfunction in temporomandibular disorders and fibromyalgia. - [1/11/2004]

51. Mood and anxiety psychopathology and temporomandibular disorder: a spectrum approach. - [1/10/2004]

52. Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. - [1/10/2004]

53. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. - [1/9/2004]

54. Quantification of the relative risk of multiple occlusal variables for muscle disorders of the stomatognathic system. - [1/8/2004]

55. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. - [1/8/2004]

56. Intra-arterial thrombolysis in basilar artery occlusion and recent haemorrhagic stroke due to arteriovenous malformation. - [1/8/2004]

57. Diagnosis of temporomandibular disorders according to RDC/TMD axis I findings, a multicenter Italian study. - [1/7/2004]

58. Is clinical assessment valid for the diagnosis of temporomandibular joint disk displacement? - [1/7/2004]

59. Mood spectrum in patients with different painful temporomandibular disorders. - [1/7/2004]

60. A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation. - [1/7/2004]

61. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. - [1/7/2004]

62. Body movements during night sleep in healthy elderly subjects and their relationships with sleep stages. - [30/6/2004]

63. Muscle relaxants in the treatment of myofascial face pain. A literature review. - [1/6/2004]

64. Psychic and occlusal factors in bruxers. - [1/6/2004]

65. Seizures induced by nursery rhymes and children's games. - [1/6/2004]

66. Far advanced otosclerosis: stapes surgery or cochlear implantation? - [1/6/2004]

67. Occlusal features are not a reliable predictor of bruxism. - [1/5/2004]

68. Clozapine for the treatment of levodopa-induced dyskinesias. - [1/5/2004]

69. Psychiatric comorbidity in a population of Parkinson's disease patients. - [1/5/2004]

70. Spontaneous arteriovenous fistula of the vertebral artery. Three case reports. - [1/5/2004]

71. Effect of medication in Parkinson's disease: a wavelet analysis of EMG signals. - [1/5/2004]

72. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections. - [1/5/2004]

73. Efficacy of tizanidine hydrochloride in the treatment of myofascial face pain. - [1/4/2004]

74. Daytime sleepiness in epilepsy patients receiving topiramate monotherapy. - [1/4/2004]

75. Eye movements: keeping vision stable. - [9/3/2004]

76. Impaired agonists recruitment during voluntary arm movements in patients affected by spasmodic torticollis. - [1/3/2004]

77. Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. - [1/3/2004]

78. The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1/2 phosphorylation. - [27/2/2004]

79. Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease. - [1/1/2004]

80. Comparing dopamine agonists in Parkinson's disease. - [1/12/2003]

81. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. - [1/11/2003]

82. Effects of calcitriol on the immune system: new possibilities in the treatment of glomerulonephritis. - [1/11/2003]

83. Predictive value of clinical findings for temporomandibular joint effusion. - [1/11/2003]

84. Ultrasound assessment of increased capsular width as a predictor of temporomandibular joint effusion. - [1/11/2003]

85. Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf. - [17/10/2003]

86. Electrophysiological evaluation of genito-sphincteric dysfunction in multiple system atrophy. - [1/10/2003]

87. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. - [1/10/2003]

88. Orthostatic hypotension in de novo Parkinson disease. - [1/10/2003]

89. Prevalence of bruxism in patients with different research diagnostic criteria for temporomandibular disorders (RDC/TMD) diagnoses. - [1/10/2003]

90. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. - [1/9/2003]

91. Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation. - [29/8/2003]

92. Free-floating cyst in the anterior chamber: ultrasound biomicroscopic reports. - [1/8/2003]

93. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. - [1/8/2003]

94. The use of hydrogen peroxide in the experimental therapy of cysts. An in vitro analysis. - [1/7/2003]

95. Etiopathogenesis of parafunctional habits of the stomatognathic system. - [1/7/2003]

96. Causative and susceptibility genes for Alzheimer's disease: a review. - [30/6/2003]

97. IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. - [24/6/2003]

98. Relevance of plasma D-dimer measurement in patients with acute peripheral vertigo. - [1/6/2003]

99. Sample size calculation for studies on temporomandibular disorders. - [1/6/2003]

100. A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus. - [1/6/2003]

101. Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice. - [30/5/2003]

102. Novel sarcoglycan gene mutations in a large cohort of Italian patients. - [1/5/2003]

103. A spectrum approach for the assessment of manic-depressive symptoms accompanying temporomandibular disorders. - [1/5/2003]

104. An unusual form of the association binding kinetics of N-[3H]methylscopolamine to the split muscarinic M2trunk/M2tail receptor. - [1/5/2003]

105. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. - [1/4/2003]

106. The relationship between anaerobic lactate threshold and plasma catecholamines during incremental exercise in hereditary spastic paraplegia. - [1/4/2003]

107. Daytime vigilance and quality of life in epileptic patients treated with vagus nerve stimulation. - [1/4/2003]

108. Contrast-enhanced three-dimensional MR angiography of neck vessels: does dephasing effect alter diagnostic accuracy? - [1/3/2003]

109. Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. - [1/3/2003]

110. The neurologist and stroke. - [1/2/2003]

111. Acute peripheral vertigo: involvement of the hemostatic system. - [1/1/2003]

112. Clinical pharmacokinetics of cabergoline. - [1/1/2003]

113. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats. - [1/1/2003]

114. Prevalence of stroke and transient ischaemic attack in the elderly population of an Italian rural community. - [1/1/2003]

115. Quercetin inhibits the sulfation of r(-)-apomorphine in human brain. - [1/1/2003]

116. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. - [1/1/2003]

117. Scala vestibuli cochlear implantation in patients with partially ossified cochleas. - [1/11/2002]

118. Vestibular-evoked myogenic potentials: a method to assess vestibulo-spinal conduction in multiple sclerosis patients. - [15/10/2002]

119. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. - [1/9/2002]

120. Amantadine in Huntington's disease: open-label video-blinded study. - [1/9/2002]

121. Dream recall frequency in epilepsy patients with partial and generalized seizures: a dream diary study. - [1/8/2002]

122. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers. - [1/7/2002]

123. 7-OH-flavone is sulfated in the human liver and duodenum, whereas 5-OH-flavone and 3-OH-flavone are potent inhibitors of SULT1A1 activity and 7-OH-flavone sulfation rate. - [1/7/2002]

124. Sulfation of R(-)-apomorphine in the human liver and duodenum, and its inhibition by mefenamic acid, salicylic acid and quercetin. - [1/7/2002]

125. Single photon emission computed tomography in otosclerosis: diagnostic accuracy and correlation with age, sex, and sensorineural involvement. - [1/7/2002]

126. Correlations between virtual endoscopy and otoendoscopy of the retrotympanum. - [1/7/2002]

127. Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy. - [1/6/2002]

128. Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients. - [1/6/2002]

129. Distal renal tubular acidosis associated with isolated large vestibular aqueduct and sensorineural hearing loss. - [1/5/2002]

130. Inhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomes. - [1/5/2002]

131. Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. - [1/5/2002]

132. Methylation of quercetin and fisetin, flavonoids widely distributed in edible vegetables, fruits and wine, by human liver. - [1/5/2002]

133. Impaired attention modulation of the blink reflex R3 component in Parkinson's disease: a non-task warning paradigm study. - [1/4/2002]

134. Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa. - [1/3/2002]

135. Treatment of patients with tardive dystonia with olanzapine. - [1/3/2002]

136. Contribution of cerebellum and brainstem in the control of eye movement: evidence from a functional study in a clinical model. - [1/1/2002]

137. Alternobaric oxygen therapy in long-term treatment of Ménière's disease. - [1/1/2002]

138. Pergolide in the treatment of patients with early and advanced Parkinson's disease. - [1/1/2002]

139. Inhibitory activity of the white wine compounds, tyrosol and caffeic acid, on lipopolysaccharide-induced tumor necrosis factor-alpha release in human peripheral blood mononuclear cells. - [1/1/2002]

140. The treatment of horizontal canal positional vertigo: our experience in 66 cases. - [1/1/2002]

141. Dissection and atherosclerosis of carotid arteries in the young: role of the apolipoprotein E polymorphism. - [1/1/2002]

142. Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. - [1/12/2001]

143. Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports. - [1/11/2001]

144. Asymmetric scalp distribution of pattern visual evoked potentials during interictal phases in migraine. - [1/11/2001]

145. Equiluminant red-green and blue-yellow VEPs in multiple sclerosis. - [1/11/2001]

146. Impaired oxidative metabolism in exercising muscle from ALS patients. - [15/10/2001]

147. Early thrombolysis in stroke due to basilar artery occlusion. - [1/10/2001]

148. A surface EMG analysis of sarcolemma excitability alteration and myofibre degeneration in Steinert disease. - [1/10/2001]

149. Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy. - [1/10/2001]

150. Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. - [1/9/2001]

151. Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. - [1/9/2001]

152. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. - [10/8/2001]

153. Temporary graft for closed-system cataract surgery during corneal triple procedures. - [1/8/2001]

154. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. - [1/7/2001]

155. Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine. - [1/6/2001]

156. Echocardiographic ultrasonic tissue characterization in a case of Fabry's disease following renal transplantation. - [1/6/2001]

157. Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. - [1/5/2001]

158. Large vestibular aqueduct in distal renal tubular acidosis. High-resolution MR in three cases. - [1/5/2001]

159. Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. - [1/5/2001]

160. Hemostatic alterations in patients with acute, unilateral vestibular paresis. - [1/4/2001]

161. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid. - [1/3/2001]

162. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. - [1/3/2001]

163. Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. - [1/2/2001]

164. Sudden bilateral hearing loss and sporadic mitochondrial DNA deletion. - [1/2/2001]

165. Effects of grating spatial orientation on visual evoked potentials and contrast sensitivity in multiple sclerosis. - [1/2/2001]

166. Circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in women with partial epilepsy in the postcritical phase. - [1/2/2001]

167. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. - [1/2/2001]

168. Cytochrome p450 and parkinsonism: protective role of CYP2E1. - [1/1/2001]

169. Apomorphine. A novel effect for an old compound. - [1/1/2001]

170. The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia. - [1/1/2001]

171. The importance of nasal resistance in obstructive sleep apnea syndrome: a study with positional rhinomanometry. - [1/1/2001]

172. Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney. - [1/12/2000]

173. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. - [1/11/2000]

174. T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients. - [1/11/2000]

175. Transient autonomic nervous system dysfunction during hyperacute stroke. - [1/11/2000]

176. Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. - [24/10/2000]

177. Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura. - [1/10/2000]

178. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. - [1/9/2000]

179. Differential inhibition of hepatic and duodenal sulfation of (-)-salbutamol and minoxidil by mefenamic acid. - [1/9/2000]

180. Mexiletine in the treatment of torticollis and generalized dystonia. - [1/7/2000]

181. Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments. - [2/6/2000]

182. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. - [1/6/2000]

183. Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis. - [1/5/2000]

184. Pharmacological prophylaxis of post-traumatic epilepsy. - [1/5/2000]

185. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. - [1/4/2000]

186. Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells. - [1/4/2000]

187. Pharmacological evidence of muscarinic receptor heterodimerization. - [1/3/2000]

188. Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. - [1/3/2000]

189. Fenamates and the potent inhibition of human liver phenol sulphotransferase. - [1/2/2000]

190. Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. - [1/1/2000]

191. Diurnal motor variations to repeated doses of levodopa in Parkinson's disease. - [1/1/2000]

192. Effects of aerobic training on lactate and catecholaminergic exercise responses in mitochondrial myopathies. - [1/1/2000]

193. Vestibular disorders in primary thrombocytosis. - [1/12/1999]

194. Changes in long-latency reflexes onset latencies across full-wave rectified and non-rectified recordings. - [1/11/1999]

195. Interethnic and interindividual variabilities of platelet sulfotransferases activity in Italians and Finns. - [1/11/1999]

196. Cortical silent period in patients with amyotrophic lateral sclerosis. - [31/10/1999]

197. Late whiplash syndrome: a clinical and magnetic resonance imaging study. - [1/10/1999]

198. The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies. - [1/10/1999]

199. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. - [1/10/1999]

200. T-lymphocyte interferon-gamma receptor binding in patients with myasthenia gravis. - [1/8/1999]

201. Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. - [1/7/1999]

202. Impaired ascendant central pathways conduction in impotent diabetic subjects. - [1/6/1999]

203. Plaque surface and microembolic signals in moderate carotid stenosis. - [1/6/1999]

204. Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. - [1/6/1999]

205. Langerhans' cells histiocytosis. - [25/4/1999]

206. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. - [1/3/1999]

207. Progressive sensorineural hearing loss in childhood. - [1/2/1999]

208. Amplitude loss of electrically and magnetically evoked sympathetic skin responses in early stages of type 1 (insulin-dependent) diabetes mellitus without signs of dysautonomia. - [1/2/1999]

209. T-cell interferon gamma receptor binding in interferon beta-1b-treated patients with multiple sclerosis. - [1/2/1999]

210. T-cell tumor necrosis factor-alpha receptor binding in myasthenic patients. - [1/1/1999]

211. L-propionyl carnitine reduces toxicity correlated to cyclosporine-induced intracellular ATP concentrations. - [1/1/1999]

212. Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis. - [1/1/1999]

213. Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease. - [1/1/1999]

214. Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells. - [1/1/1999]

215. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. - [1/12/1998]

216. Volumetric analysis of CT orbital images. - [1/11/1998]

217. T-lymphocyte interleukin 6 receptor binding in patients with dementia of Alzheimer type. - [1/10/1998]

218. Immunohistochemical localisation of tear lipocalin in human nasal mucosa. - [1/9/1998]

219. Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. - [21/8/1998]

220. Verapamil prevents cyclosporine-induced hypertension by modulating endothelin A receptor expression in rat kidney membranes. - [1/8/1998]

221. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. - [1/8/1998]

222. Anterior suspended flaps: a modified approach for external dacryocystorhinostomy. - [1/7/1998]

223. Flunarizine in migraine prophylaxis: predictive factors for a positive response. - [1/7/1998]

224. T-cell interleukin-6 receptor binding in patients with myasthenia gravis. - [30/6/1998]

225. Evaluation of acute ischemic stroke using quantitative EEG: a comparison with conventional EEG and CT scan. - [1/6/1998]

226. Interindividual variability of histamine N-methyltransferase in the human liver and kidney. - [1/6/1998]

227. Catechol-O-methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone. - [1/5/1998]

228. Progressive sensorineural hearing impairment in systemic vasculitides. - [1/4/1998]

229. Sarcolemmal excitability in myotonic dystrophy: assessment through surface EMG. - [1/4/1998]

230. Bilateral medial frontal infarction in a case of azygous anterior cerebral artery stenosis. - [1/4/1998]

231. Ultrasonographic and angiographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. - [1/1/1998]

232. Sensitivity and specificity of ultrasonography, fluorescein videoangiography, indocyanine green videoangiography, magnetic resonance and radioimmunoscintigraphy in the diagnosis of primary choroidal malignant melanoma. - [1/1/1998]

233. Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy. - [1/1/1998]

234. Reliability of standardized echography before vitreoretinal surgery for proliferative diabetic retinopathy. - [1/1/1998]

235. Standardized echography, pattern electroretinography and visual-evoked potential and automated perimetry in the early diagnosis of Graves' neuropathy. - [1/1/1998]

236. Echographic study of the vitreoretinal interface in giant retinal tears. - [1/1/1998]

237. Neuro-laryngeal involvement in Churg-Strauss syndrome. - [1/1/1998]

238. Ultrasound biomicroscopy in the assessment of secondary glaucoma after vitreoretinal surgery and silicone oil injection. - [1/1/1998]

239. Ultrasound biomicroscopy in the assessment of penetrating or blunt anterior-chamber trauma. - [1/1/1998]

240. A comparison of skin storage methods for oculoplastic surgery. - [1/1/1998]

241. Herpes zoster oticus: correlations between clinical and MRI findings. - [1/1/1998]

242. Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report. - [1/1/1998]

243. Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration. - [1/12/1997]

244. Central motor pathway evaluation using magnetic coil stimulation in hereditary motor and sensory neuropathy type I (HMSN type I, Charcot-Marie-Tooth disease). - [1/12/1997]

245. Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease. - [1/10/1997]

246. Changes in pain perception and pain-related somatosensory evoked potentials in humans produced by exposure to oscillating magnetic fields. - [26/9/1997]

247. Carotid plaque features on angiography and asymptomatic cerebral microembolism. - [1/9/1997]

248. Damage of foldable intraocular lenses by incorrect folder forceps. - [1/8/1997]

249. A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients. - [1/4/1997]

250. T-cell tumor necrosis factor-alpha receptor binding in patients with multiple sclerosis. - [1/4/1997]

251. Alteration of cardiac function in patients with temporal lobe epilepsy: different roles of EEG-ECG monitoring and spectral analysis of RR variability. - [1/3/1997]

252. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm. - [1/1/1997]

253. Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's disease. - [1/1/1997]

254. Silent cerebral microembolism in asymptomatic and symptomatic carotid artery stenoses of low and high degree. - [1/1/1997]

255. FK-506 delays corneal graft rejection in a model of corneal xenotransplantation. - [1/1/1996]

1. Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. - [1/5/2006]

2. Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation. - [1/5/2006]

3. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer. - [1/5/2006]

4. Biomolecular markers of breast cancer. - [1/5/2006]

5. Binding free energy calculations of adenosine deaminase inhibitors. - [15/4/2006]

6. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha(1)-, alpha(2)-adrenergic and 5-HT(1A) serotoninergic receptors. - [15/4/2006]

7. Predictors of symptom recurrence after low-dose inhaled corticosteroid cessation in mild persistent asthma. - [1/4/2006]

8. Defective thyroglobulin storage in LDL receptor-associated protein-deficient mice. - [1/4/2006]

9. Evaluation of Fungicidal Efficacy of Benzalkonium Chloride (Steramina G u.v.) and Virkon-S against Microsporum canis for Environmental Disinfection. - [1/4/2006]

10. Hypnotic trait and specific phobia: EEG and autonomic output during phobic stimulation. - [31/3/2006]

11. Preparation and biological evaluation of some 1,2-O-isopropylidene-d-hexofuranose esters. - [20/3/2006]

12. Solvation of Coumarin 153 in Supercritical Fluoroform. - [16/3/2006]

13. Perineal swelling, intermenstrual cycle, and female sexual behavior in bonobos (Pan paniscus). - [13/3/2006]

14. DjPiwi-1, a member of the PAZ-Piwi gene family, defines a subpopulation of planarian stem cells. - [11/3/2006]

15. Xenopus Xotx2 and Drosophila otd share similar activities in anterior patterning of the frog embryo. - [11/3/2006]

16. A new hydrogel for the extended and complete prednisolone release in the GI tract. - [9/3/2006]

17. Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport. - [7/3/2006]

18. A detector head design for small-animal PET with silicon photomultipliers (SiPM). - [7/3/2006]

19. Stereoselective synthesis of chiral 3-aryl-1-alkynes from bromoallenes and heterocuprates. - [3/3/2006]

20. Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy. - [1/3/2006]

21. Epistaxis after PDE-5 inhibitors misuse. - [1/3/2006]

22. Pentose phosphates in nucleoside interconversion and catabolism. - [1/3/2006]

23. The pancreatic beta-cell in human Type 2 diabetes. - [1/3/2006]

24. Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. - [1/3/2006]

25. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. - [1/3/2006]

26. Ultrastructural and cytochemical aspects of the female gonad of Geoplana burmeisteri (Platyhelminthes, Tricladida, Terricola). - [1/3/2006]

27. Social play in bonobos (Pan paniscus) and chimpanzees (Pan troglodytes): Implications for natural social systems and interindividual relationships. - [1/3/2006]

28. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. - [1/3/2006]

29. A membrane-permeable peptide containing the last 21 residues of the G alpha(s) carboxyl terminus inhibits G(s)-coupled receptor signaling in intact cells: correlations between peptide structure and biological activity. - [1/3/2006]

30. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. - [1/3/2006]

31. The "non-nucleophilic" anion [Tf(2)N](-) competes with the nucleophilic Br(-): an unexpected trapping in the dediazoniation reaction in ionic liquids. - [28/2/2006]

32. Identification of garlic in old gildings by gas chromatography-mass spectrometry. - [24/2/2006]

33. A theoretical study to investigate D2DAR/D4DAR selectivity: receptor modeling and molecular docking of dopaminergic ligands. - [23/2/2006]

34. CAROTID VASCULAR REMODELING IN PATIENTS WITH PHEOCHROMOCYTOMA. - [21/2/2006]

35. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. - [21/2/2006]

36. Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. - [21/2/2006]

37. VASCULAR REACTIVITY IN CONGENITAL HYPOGONADAL MEN BEFORE AND AFTER TESTOSTERONE REPLACEMENT THERAPY. - [21/2/2006]

38. Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. - [20/2/2006]

39. Stereoselective uncatalyzed synthesis of 2,3-unsaturated-4-n-substituted-beta-O-glycosides by means of a new D-galactal-derived N-(mesyl)-aziridine. - [17/2/2006]

40. Colorimetric coupled enzyme assay for gamma-glutamyltransferase activity using glutathione as substrate. - [17/2/2006]

41. Modeling a liquid crystal dynamics by atomistic simulation with an ab initio derived force field. - [16/2/2006]

42. Efficacy of an essentifal oil of Cinnamomum zeylanicum against Psoroptes cuniculi. - [15/2/2006]

43. Dystroglycan is required for proper retinal layering. - [15/2/2006]

44. Impact of incretin hormones on {beta}-cell function in subjects with normal or impaired glucose tolerance. - [14/2/2006]

45. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides. - [14/2/2006]

46. Epilepsy in children. - [11/2/2006]

47. Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. - [10/2/2006]

48. Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. - [9/2/2006]

49. Identification of sugar-modulated genes and evidence for in vivo sugar sensing in Arabidopsis. - [7/2/2006]

50. Cellular biomarkers for monitoring estuarine environments: Transplanted versus native mussels. - [7/2/2006]

51. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. - [1/2/2006]

52. Characterization of LEAFY COTYLEDON1-LIKE gene in Helianthus annuus and its relationship with zygotic and somatic embryogenesis. - [1/2/2006]

53. Acute effects of hemodialysis on left ventricular function evaluated by tissue Doppler imaging. - [1/2/2006]

54. Triterpenoid saponins from Campsiandra guayanensis. - [1/2/2006]

55. Extracorporeal repair and liver autotransplantation after total avulsion of hepatic veins and retrohepatic inferior vena cava injury secondary to blunt abdominal trauma. - [1/2/2006]

56. Which endothelium-derived factors are really important in humans? - [1/2/2006]

57. Self-perceived normality in defecation habits. - [1/2/2006]

58. Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. - [1/2/2006]

59. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. - [1/2/2006]

60. Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates. - [1/2/2006]

61. Autoradiographic localization and binding study of benzodiazepines receptor sites in carp brain (Cyprinus carpio L.). - [1/2/2006]

62. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients. - [1/2/2006]

63. Histopathological studies of sclerotia of phytopathogenic fungi parasitized by a GFP transformed Trichoderma virens antagonistic strain. - [1/2/2006]

64. A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. - [1/2/2006]

65. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. - [1/2/2006]

66. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. - [1/2/2006]

67. Thymomas: clinical-pathological correlations. - [1/2/2006]

68. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. - [1/2/2006]

69. Practitioner review: use of antiepileptic drugs in children. - [1/2/2006]

70. Cytogenetic biomarkers, urinary metabolites and metabolic gene polymorphisms in workers exposed to styrene. - [1/2/2006]

71. XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development. - [1/2/2006]

72. Sucrose-specific induction of the anthocyanin biosynthetic pathway in Arabidopsis. - [1/2/2006]

73. Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging Study. - [31/1/2006]

74. Bulimia nervosa in atypical depression: The mediating role of cyclothymic temperament. - [22/1/2006]

75. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies. - [21/1/2006]

76. Mangafodipir trisodium-enhanced MR imaging of pancreatic disease. - [19/1/2006]

77. Adenosine receptor modelling. A(1)/A(2a) selectivity. - [17/1/2006]

78. Prediction of hERG potassium channel affinity by the CODESSA approach. - [17/1/2006]

79. Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. - [13/1/2006]

80. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. - [12/1/2006]

81. HIV-1 NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor. - [1/1/2006]

82. Langerhans' cell histiocytosis: a case report of an eosinophilic granuloma of the mandible treated with bone graft surgery and endosseous titanium implants. - [1/1/2006]

83. NO-Releasing Hybrids of Cardiovascular Drugs. - [1/1/2006]

84. Is insulin resistance the cause of the metabolic syndrome? - [1/1/2006]

85. Artifactual changes in canine blood following storage, detected using the ADVIA 120 hematology analyzer. - [1/1/2006]